Zifan Pei

1.9k total citations · 6 hit papers
43 papers, 1.4k citations indexed

About

Zifan Pei is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Zifan Pei has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Biomedical Engineering, 14 papers in Molecular Biology and 12 papers in Materials Chemistry. Recurrent topics in Zifan Pei's work include Nanoplatforms for cancer theranostics (22 papers), Advanced Nanomaterials in Catalysis (9 papers) and interferon and immune responses (5 papers). Zifan Pei is often cited by papers focused on Nanoplatforms for cancer theranostics (22 papers), Advanced Nanomaterials in Catalysis (9 papers) and interferon and immune responses (5 papers). Zifan Pei collaborates with scholars based in China, Macao and United States. Zifan Pei's co-authors include Liang Cheng, Huali Lei, Yuqi Yang, Nailin Yang, Zhuang Liu, Zhihui Han, Chenyu Jiang, Fei Gong, Theodore Cummins and Li Wang and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.

In The Last Decade

Zifan Pei

41 papers receiving 1.4k citations

Hit Papers

Bioactive inorganic nanomaterials for cancer theranostics 2023 2026 2024 2025 2023 2023 2024 2024 2025 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zifan Pei China 21 732 410 360 227 195 43 1.4k
Jianqin Yan China 23 519 0.7× 622 1.5× 240 0.7× 317 1.4× 112 0.6× 71 1.4k
Hongzhuo Liu China 23 524 0.7× 518 1.3× 252 0.7× 532 2.3× 127 0.7× 58 1.5k
Mao Wang China 13 598 0.8× 348 0.8× 628 1.7× 115 0.5× 126 0.6× 33 1.4k
Kewei Wang China 21 644 0.9× 559 1.4× 278 0.8× 319 1.4× 88 0.5× 38 1.2k
Lu Tang China 20 633 0.9× 431 1.1× 295 0.8× 337 1.5× 146 0.7× 44 1.2k
Kayvan Sadri Iran 23 320 0.4× 374 0.9× 338 0.9× 336 1.5× 143 0.7× 56 1.3k
Xingwu Jiang China 28 1.4k 1.9× 612 1.5× 876 2.4× 402 1.8× 132 0.7× 61 2.3k

Countries citing papers authored by Zifan Pei

Since Specialization
Citations

This map shows the geographic impact of Zifan Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifan Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifan Pei more than expected).

Fields of papers citing papers by Zifan Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zifan Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifan Pei. The network helps show where Zifan Pei may publish in the future.

Co-authorship network of co-authors of Zifan Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Zifan Pei. A scholar is included among the top collaborators of Zifan Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zifan Pei. Zifan Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shumin, Nailin Yang, Zifan Pei, et al.. (2025). Ferrous fluoride nanoinitiators reprogram tumor stemness to empower ultrasound-augmented pyroptosis for potent catalytic immunotherapy. Biomaterials. 326. 123652–123652. 3 indexed citations
2.
Gong, Fei, Yuqi Yang, Zifan Pei, et al.. (2025). A Gas Nanobomb to Promote Drug Penetration and Amplify TACE Therapy for Orthotopic Liver Tumor. Advanced Materials. 37(39). e2505770–e2505770. 3 indexed citations
3.
Yang, Nailin, et al.. (2025). Biomedical engineering targeting cancer stem cells to reinforce cancer therapy. Coordination Chemistry Reviews. 530. 216494–216494. 9 indexed citations
4.
Wu, Jie, Zhicheng Liu, Li Wang, et al.. (2025). Hydrotalcites-Induced Pyroptosis Combined with Toll-Like Receptor Activation Elicited Dual Stimulation of Innate and Adaptive Immunity. ACS Nano. 19(8). 8070–8084. 11 indexed citations
5.
Sun, Shumin, Nailin Yang, Zixian Yang, et al.. (2025). Nanomaterials intervene in cell senescence to reinforce cancer therapy. Coordination Chemistry Reviews. 545. 217012–217012. 5 indexed citations
6.
Yang, Nailin, Yu‐Dong Cai, Shumin Sun, et al.. (2025). Hydrogen sulfide in cancer therapy: Intelligent delivery platforms and synergistic therapeutic paradigms. Advanced Drug Delivery Reviews. 227. 115717–115717.
7.
Pei, Zifan, et al.. (2024). Bioactive metal-based nanomedicines for boosting anti-tumor immunity: Advance, challenge, and perspective. Coordination Chemistry Reviews. 517. 215969–215969. 17 indexed citations
8.
Yang, Nailin, Shumin Sun, Li Wang, et al.. (2024). Antimony Component Schottky Nanoheterojunctions as Ultrasound‐Heightened Pyroptosis Initiators for Sonocatalytic Immunotherapy. Angewandte Chemie International Edition. 64(4). e202416426–e202416426. 27 indexed citations
9.
Yin, Yifan, Zifan Pei, Chengyu Hu, et al.. (2024). A potent nano-strategy for dual energy deprivation to inhibit pancreatic cancer progression. Nano Today. 59. 102528–102528. 7 indexed citations
10.
Pei, Zifan, Nan Jiang, Fei Gong, et al.. (2024). A metal anion strategy to induce pyroptosis combined with STING activation to synergistically amplify anti-tumor immunity. Materials Today. 80. 23–39. 11 indexed citations
11.
Wu, Jie, Li Wang, Wei Tang, et al.. (2023). Amplifying oxidation stress and T-cell activation by bioactive layered double hydroxide sonosensitizers for enhanced cancer immunotherapy. Materials Today. 68. 164–176. 36 indexed citations
12.
Panarelli, Joseph F., Michael Tepedino, Noriko Odani‐Kawabata, et al.. (2023). Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study. Journal of Glaucoma. 32(12). 999–1005. 6 indexed citations
13.
Pei, Zifan, Huali Lei, & Liang Cheng. (2023). Bioactive inorganic nanomaterials for cancer theranostics. Chemical Society Reviews. 52(6). 2031–2081. 165 indexed citations breakdown →
15.
Lei, Huali, Quguang Li, Zifan Pei, et al.. (2023). Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy. Small. 19(45). e2303438–e2303438. 33 indexed citations
16.
Lei, Huali, Quguang Li, Guangqiang Li, et al.. (2023). Manganese molybdate nanodots with dual amplification of STING activation for “cycle” treatment of metalloimmunotherapy. Bioactive Materials. 31. 53–62. 57 indexed citations
17.
Xiao, Yucheng, et al.. (2020). S-Palmitoylation of the sodium channel Nav1.6 regulates its activity and neuronal excitability. Journal of Biological Chemistry. 295(18). 6151–6164. 21 indexed citations
18.
Xiao, Yucheng, Cindy Barbosa, Zifan Pei, et al.. (2019). Increased Resurgent Sodium Currents in Nav1.8 Contribute to Nociceptive Sensory Neuron Hyperexcitability Associated with Peripheral Neuropathies. Journal of Neuroscience. 39(8). 1539–1550. 43 indexed citations
19.
Pei, Zifan, Yucheng Xiao, Jingwei Meng, Andy Hudmon, & Theodore Cummins. (2016). Cardiac sodium channel palmitoylation regulates channel availability and myocyte excitability with implications for arrhythmia generation. Nature Communications. 7(1). 12035–12035. 55 indexed citations
20.
Lu, Wenjie, Cong Xu, Zifan Pei, et al.. (2011). The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents. Breast Cancer Research and Treatment. 133(1). 99–109. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026